Concert Pharma Gets 2nd FTC Request Over Vertex Deal
Massachusetts-based Concert Pharmaceuticals Inc. has received a second request for information from the Federal Trade Commission for the planned sale of its investigational cystic fibrosis treatment to Vertex Pharmaceuticals Inc. in...To view the full article, register now.
Already a subscriber? Click here to view full article